Atrium Therapeutics, Inc. Common Stock (RNA)

Atrium Therapeutics, Inc. Common Stock (RNA) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $130M; returns 1 day +0.5%, 1 week +6.9%, 1 year -83.1%.

Atrium Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing precision RNA therapeutics targeted directly to the heart.

Groups RNA belongs to

• Clinical Stage Biotech
• Clinical Stage Biopharma
• Clinical Stage
• Biotechnology
• Biopharmaceutical
• Precision Medicine
• Rare Diseases
• Cardiovascular Therapies

RNA financial model: income statement, cash flow and balance sheet